ARAF and non-small cell lung carcinoma: Clinicopathologic characteristics of NSCLC patients harboring FGFR3 mutations, AKT1 mutations, EGFR ECD mutations, HER2 ECD and transmembrane domain mutations, ARAF mutations or NRG1 fusions